InPractice Survey on the Treatment of Hypercholesterolemia

Evaluation of the Effects of Simvastatin 40mg

NCT00397826 ·Status: COMPLETED ·Phase: PHASE4

Polish Survey on the Efficacy of the Hypercholesterolemia Treatment

NCT01243255 ·Status: COMPLETED

Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention

NCT06281041 ·Status: COMPLETED

Effect of Intensive Lipid-Lowering Therapy on Coronary Atherosclerotic Plaque Progression in Young and Middle-Aged Patients With Chronic Coronary Syndrome

NCT06896708 ·Status: RECRUITING ·Phase: NA

Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug Therapy in Korea

NCT01372956 ·Status: COMPLETED

Efficacy of Lipid-Lowering Therapy Based on Apolipoprotein B Versus LDL-Cholesterol Levels in Patients Undergoing Percutaneous Coronary Intervention

NCT06626126 ·Status: NOT_YET_RECRUITING ·Phase: NA

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

NCT01190072 ·Status: TERMINATED

Familial Atherosclerosis Treatment Study

NCT00000512 ·Status: COMPLETED ·Phase: PHASE3

Colchicine Use for Primary Prevention of Coronary Artery Disease

NCT05175274 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

NCT04826354 ·Status: COMPLETED ·Phase: PHASE4

Intensive Lipid Lowering Treatment in Non-ST-elevation Acute Coronary Syndrome (NSTE-ACS) Patients

NCT01040936 ·Status: UNKNOWN ·Phase: PHASE4

The Food Effect on Pharmacokinetics and Safety of Fixed-dose Combination of CJ-30056 in Healthy Male Subjects

NCT02160743 ·Status: COMPLETED ·Phase: PHASE1

Optimal Attained LDL-Cholesterol Levels in Patients Who Achieved ≥50% LDL Reduction After PCI

NCT06338956 ·Status: COMPLETED

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

NCT05361421 ·Status: RECRUITING ·Phase: PHASE4

A Study of PCSK9 Inhibitor AK102 in Patients With Hypercholesterolemia

NCT04358432 ·Status: COMPLETED ·Phase: PHASE2

Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography

NCT06863545 ·Status: RECRUITING ·Phase: NA

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

NCT05325034 ·Status: RECRUITING ·Phase: NA

Plaque Reversal With Early, Aggressive Lipid Lowering Therapy

NCT05783804 ·Status: RECRUITING

How Atorvastatin Affects the Gut Flora and Metabolomics?

NCT04215237 ·Status: UNKNOWN ·Phase: NA

Identification of CETP as a Marker of Atherosclerosis

NCT02081066 ·Status: COMPLETED ·Phase: NA

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

NCT00329069 ·Status: COMPLETED ·Phase: NA

Physical Activity Levels and Statin Therapy

NCT05625945 ·Status: COMPLETED

Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive Care

NCT01105325 ·Status: TERMINATED

Hepatic Safety of Statin Use in Neurology Inpatients

NCT06592196 ·Status: RECRUITING

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial

NCT02601157 ·Status: COMPLETED ·Phase: PHASE4